Searchable abstracts of presentations at key conferences in endocrinology

ea0011oc23 | Clinical endocrinology | ECE2006

Improved Prognosis in Midgut Carcinoid patients by treating raised circulating Neurokinin A (NKA)

Ardill JES , Johnston BJ , Turner GB , McGinty A , McCance DR

Midgut Carcinoid disease (MGC) is uncommon, occurring in approximately 1.4 per 100,000 of the population per year. MGC has an unpredictable disease progression varying from rapid and aggressive to slow and indolent. For this reason it is not appropriate to treat all patients according to the same schedule. As some treatments are not without risk, it is important to identify those patients selected for these options at an appropriate stage of disease.In a...

ea0070aep350 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

PHIGNA-DM2 study: Fatty liver and nonalcoholic steatohepatitis prevalence in type 2 diabetes in an andalusian cohort

Jesús Martínez Ortega Antonio , Remon Pablo , Deniz Garcia Alejandro , Ampuero Javier , Romero-Gomez Manuel , Pablo Garcia-Luna Pedro , Soto-Moreno Alfonso

Introduction: Non-alcoholic fatty liver disease (NAFLD) is an underdiagnosed complication in Type 2 Diabetes (T2D). This condition can evolve into steatohepatitis (NASH) and more severe entities such as liver cirrhosis and hepatic failure, being currently the first cause for liver transplantation in our environment. In Andalusian T2D patients, the exact prevalence is still unknown. Our aim is to assess the prevalence of NAFLD/NASH in a cohort of these patients.<p class="ab...

ea0014p120 | (1) | ECE2007

Ret expression reduces estrogen-induced lactotrope hyperplasia

Cañibano Carmen , Rodríguez Noela , Tovar Sulay , Vázquez María Jesús , Lavandeira Montserrat , Díeguez Carlos , Álvarez Clara

RET is a tyrosine kinase receptor activated by GDNF, NTN, ART and PSPN through GFRa1,2, 3 and 4 respectively. Activation of the receptor elicits intracellular pathways such us Ras/MAPK and PI3K/AKT leading to differentiation and proliferation. Our group has previously shown that RET is expressed specifically in the somatotroph cell population within the pituitary gland, both in rats and in humans. We have also shown that, in absence of its ligand GDNF, RET induces activation o...

ea0073aep466 | Pituitary and Neuroendocrinology | ECE2021

Study of the brain system for motor control in prader willi syndrome

Blanco Laura , Casamitjana Laia , Jesús Pujol , Gerard Martínez-Vilavella , Deus Joan , Olga Giménez-Palop , Assumpta Caixàs

BackgroundPrader Willi syndrome (PWS) is a genetic disorder with a broad clinical expression. Severe hypotonia with feeding difficulties during early infancy and delayed motor development are very characteristic. At older ages, common motor features in the PWS phenotype include decreased muscle strength, deficiencies in motor coordination and sequencing, gait disturbances and dyspraxic manifestations, with no clear pathophysiological mechanism yet identi...

ea0070aep993 | Thyroid | ECE2020

125I radioactive seed localization (RSL) in surgery of cervical metastasis of thyroid cancer

Jesús García González Juan , Martín Hernández Tomás , Domínguez Rabadán Rocío , Reyes Ravé García María , Rodríguez Vera Pablo

Introduction: The aim of this work is the evaluation of usefulness of radioactive seed localization (RSL) for the detection of cervical recurrence of thyroid cancer in order to improve the surgical outcome.Material and method: Six patients with thyroid cancer with cervical recurrences evidenced by ultrasound, cytology/Tg-FNAB were selected for this procedure. A 125I seed was placed in the metastatic lesion using a needle guided by ultrasound. ...

ea0070ep296 | Pituitary and Neuroendocrinology | ECE2020

Prevalence of hypocortisolism and replacement treatment after transsphenoidal surgery pituitary adenomas

del Mar Roca-Rodriguez Maria , Manuel Cornejo-Domínguez Jesús , Vidal-Suárez Álvaro , Muriel-Cueto Pedro , Iglesias-Lozano Irene , Gavilán-Villarejo Inmaculada , Aguilar-Diosdado Manuel

Aim: Evaluation of hypocortisolism and replacement treatment after transsphenoidal surgery pituitary adenomas and subsequent follow-up in Endocrinology offices.Material and methodWe conducted a retrospective intra-subject study of patients with pituitary adenomas who were undergone surgery. Clinical and analytical data were evaluated at baseline and after surgery between 2012–2018.Results: 30 patients (...

ea0014p226 | (1) | ECE2007

Frequency of hypogonadism in males with type 2 diabetes and its relation with erectile dysfunction and obesity

García-Malpartida Katherinne , Casañ-Fernández Rosa , Yanini-García Jesús , Jover-Fernández Ana , Gómez-Balaguer Marcelino , Solá-Izquierdo Eva , Morillas-Ariño Carlos , Hernández-Mijares Antonio

Introduction: The aim of our study was to determine the frequency of hypogonadism (H) in males with type 2 diabetes (T2D) and its relation with erectile dysfunction (ED) and obesity.Methods: We studied 107 diabetic males who came successively to an Endocrine consultation. The presence of H was determined by total testosterone (T) with an immunofluerescence method and free testosterone (fT) calculated with Vermeulen’s equation, defining H if T<2 ...

ea0073aep241 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

GLP-1 receptor agonists and bariatric surgery in nonalcoholic steatohepatitis

Soraya León , María Dolores Alcántara-Laguna , Maria José Molina , Alfonso Jesús Calañas Continente , Concepción Muñoz , Maria Angeles Galvez Moreno , Aura D. Herrera-Martínez

RationaleObesity is associated with multiple comorbidities including nonalcoholic steatohepatitis (NASH). Despite its association with increased morbidity and mortality, treatment options are limited. Some studies have suggested that glucagon-like peptide-1 receptor agonists (aGLP-1) are associated with NASH resolution. Additionally, the effects of bariatric surgery on NASH-associated liver fibrosis are controversial.Methods<p ...

ea0070oc9.1 | Reproductive and Developmental Endocrinology | ECE2020

Identification of a novel hypothalamic miRNA/Kisspeptin pathway as pathophysiological mechanism and putative target for management of obesity-induced hypogonadism

Perdices López Cecilia María , Avendaño Herrador María Soledad , Vázquez Villar María Jesús , Barroso Romero Alexia , Ruiz Pino Francisco , Morrugares Carmona Rosario , Correa Sáez Alejandro , Antonio Calzado Marco , Castellano Rodríguez Juan Manuel , Briones Alonso Ana María , Tena-Sempere Manuel

Among its numerous comorbidities, obesity is often linked to central hypogonadism in men, i.e., low circulating levels of gonadotropins and testosterone. While this condition of obesity-induced hypogonadism (OIH) is frequently neglected, it has been suggested to contribute to the metabolic complications of male obesity. However, the mechanisms of OIH, and even its actual role in the metabolic alterations of obesity remain ill defined. Our recent data suggest that OIH is bound ...

ea0070aep284 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Inflammasome components and food addiction behaviors in morbid obesity and bariatric surgery: Novel promising targets for a chronic disease

Herrero-Aguayo Vicente , Sáez-Martínez Prudencio , Luis López-Cánovas Juan , Jesús Montero-Hidalgo Antonio , Membrives Antonio , David Gahete Manuel , José Molina-Puerta María , Pastor Castaño Justo , Ángeles Gálvez-Moreno María , Miguel Luque Raúl , Dulcinea Herrera-Martínez Aura

Obesity is a chronic metabolic disease associated with important metabolic and inflammatory comorbidities, which can be reversed or improved after bariatric-surgery (BS). However, some underlying mechanisms, independent of weight-loss, are still unknown. In this context, dysregulations in the inflammasome, a multiproteic complex that promotes cytokine maturation and induces cellular pyroptosis, has been associated to the development/stage of some cancer-types and obesity. Howe...